|Save ComparisonClear all|
Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur.
The Diaxonhit group is a French fully integrated leader in the field of in-vitro diagnostic with expertise ranging from discovery to commercialization of specialty diagnostic products.
MedRhythms is committed to providing patients with digital therapeutics and services that facilitate recovery from neurological injuries and diseases.
Curai helps patients to deliver the right information to doctors.
LYTICS is an artificial intelligence company serving the healthcare community in solving complex medical and clinical issues with point solutions.
Redwood City, US HQ
Paris, FR HQ
Portland, US HQ
Palo Alto, US HQ
Malmö, SE HQ
Palo Alto, US
Facebook likes3.4 k
Twitter followers1.3 k
Latest funding round
Latest funding round$ 13.7m (8 months ago)
Latest funding roundN/A
Latest funding round$ 5.3m (5 months ago)
Latest funding round$ 10.7m (6 months ago)
Latest funding round$ 580k (over 1 year ago)
Total funding raised
Total funding raised$ 26.1m
Total funding raisedN/A
Total funding raised$ 5.3m
Total funding raised$ 10.7m
Total funding raised$ 1.1m